These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28375670)

  • 21. [Effects of thromboendarterectomy for post-embolic pulmonary hypertension on physiological dead space on exercise].
    Botelho AD; Tercé G; Stervinou-Wemeau L; Robin S; Wallaert B
    Rev Mal Respir; 2011 Mar; 28(3):377-80. PubMed ID: 21482345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inspiratory muscle weakness contributes to exertional dyspnea in chronic thromboembolic pulmonary hypertension.
    Rolim JV; Ota-Arakaki JS; Ferreira EVM; Figliolino GAM; Ivanaga I; Vieira EB; Fonseca AXC; Messina CMS; Costa CM; Neder JA; Nery LE; Ramos RP
    PLoS One; 2018; 13(9):e0204072. PubMed ID: 30260970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity.
    Wallaert B; Talleu C; Wemeau-Stervinou L; Duhamel A; Robin S; Aguilaniu B
    Respiration; 2011; 82(6):501-8. PubMed ID: 21934275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exercise Testing, Supplemental Oxygen, and Hypoxia.
    Ward SA; Grocott MPW; Levett DZH
    Ann Am Thorac Soc; 2017 Jul; 14(Supplement_1):S140-S148. PubMed ID: 28590162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in Exercise Capacity, Ventilatory Efficiency, and Gas Exchange between Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Residing at High Altitude.
    Gonzalez-Garcia M; Conde-Camacho R; Díaz K; Rodríguez-Cortes C; Rincon-Alvarez E
    Rev Cardiovasc Med; 2024 Jul; 25(7):247. PubMed ID: 39139420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiopulmonary Exercise Testing and Metabolic Myopathies.
    Riley MS; Nicholls DP; Cooper CB
    Ann Am Thorac Soc; 2017 Jul; 14(Supplement_1):S129-S139. PubMed ID: 28590155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of cardiopulmonary exercise testing in the assessment of pulmonary hypertension].
    Dumitrescu D; Rosenkranz S
    Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S176-9. PubMed ID: 18814090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventilatory and sensory responses in adult survivors of preterm birth and bronchopulmonary dysplasia with reduced exercise capacity.
    Lovering AT; Elliott JE; Laurie SS; Beasley KM; Gust CE; Mangum TS; Gladstone IM; Duke JW
    Ann Am Thorac Soc; 2014 Dec; 11(10):1528-37. PubMed ID: 25380058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Submaximal cardiopulmonary exercise testing for the evaluation of unexplained dyspnea.
    Bhatt DV; Kocheril AG
    South Med J; 2014 Mar; 107(3):144-9. PubMed ID: 24937330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical value of cardiopulmonary exercise testing in the modern era.
    Laveneziana P; Di Paolo M; Palange P
    Eur Respir Rev; 2021 Mar; 30(159):. PubMed ID: 33408087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise Pulmonary Hypertension Predicts Clinical Outcomes in Patients With Dyspnea on Effort.
    Ho JE; Zern EK; Lau ES; Wooster L; Bailey CS; Cunningham T; Eisman AS; Hardin KM; Farrell R; Sbarbaro JA; Schoenike MW; Houstis NE; Baggish AL; Shah RV; Nayor M; Malhotra R; Lewis GD
    J Am Coll Cardiol; 2020 Jan; 75(1):17-26. PubMed ID: 31918830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and safety of cardiopulmonary exercise testing in children with pulmonary hypertension.
    Abumehdi MR; Wardle AJ; Nazzal R; Charalampopoulos A; Schulze-Neick I; Derrick G; Moledina S; Giardini A
    Cardiol Young; 2016 Aug; 26(6):1144-50. PubMed ID: 26374593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early-Phase Recovery of Cardiorespiratory Measurements after Maximal Cardiopulmonary Exercise Testing in Patients with Chronic Obstructive Pulmonary Disease.
    Bellefleur M; Debeaumont D; Boutry A; Netchitailo M; Cuvelier A; Muir JF; Tardif C; Coquart J
    Pulm Med; 2016; 2016():9160781. PubMed ID: 28018674
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of dyspnea in advanced pulmonary arterial hypertension.
    Sajkov D; Petrovsky N; Palange P
    Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced muscle strength, exercise intolerance and disabling symptoms in sarcoidosis.
    Marcellis RG; Lenssen AF; de Vries J; Drent M
    Curr Opin Pulm Med; 2013 Sep; 19(5):524-30. PubMed ID: 23851328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary Hypertension and Exercise.
    Vallerand JR; Weatherald J; Laveneziana P
    Clin Chest Med; 2019 Jun; 40(2):459-469. PubMed ID: 31078222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity.
    Neal JE; Lee AS; Burger CD
    Clin Respir J; 2014 Oct; 8(4):404-9. PubMed ID: 24308300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary Vascular Disease and Cardiopulmonary Exercise Testing.
    Laveneziana P; Weatherald J
    Front Physiol; 2020; 11():964. PubMed ID: 32848882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The invasive cardiopulmonary exercise test.
    Maron BA; Cockrill BA; Waxman AB; Systrom DM
    Circulation; 2013 Mar; 127(10):1157-64. PubMed ID: 23479667
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiopulmonary exercise testing in patients with pulmonary hypertension: clinical recommendations based on a review of the evidence.
    Pinkstaff SO; Burger CD; Daugherty J; Bond S; Arena R
    Expert Rev Respir Med; 2016; 10(3):279-95. PubMed ID: 26789612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.